Serbia’s economy ministry said a total of 10 companies have purchased tender documents for the privatisation of ailing pharmaceutical firm Galenika by September 20 deadline, local media reported.
Potential buyers will be able to place their bids until October 2, public broadcaster RTS quoted sources from the economy ministry as saying.
The Serbian government launched the tender for the sale of Galenika on September 1. The minimum price was set at 25 million euro ($29.7 million) for the repayment of Galenika’s debt plus 1 euro for the tendering, news agency Tanjug said earlier this month.
On August 14, Galenika shareholders gave the green light to the conversion of debt to the government into equity, opening the way for the privatisation of the company.
The government now holds a 93% stake in Galenika, with the remaining 7% in the hands of retail investors.
In March, the government cancelled a procedure for the privatisation of Galenika under a proposal of the commission that had held negotiations with the sole bidder, a British-Russian consortium.
- Serbia and China sign several important documents
- Chinese investor to build 80 mln euro zinc oxide factory in Serbia
- IMF: Serbia alone received over half of region's FDIs
- Arabs to buy faltering Serbian agriculture giant
- Germany's Leoni to invest 60 mln euro in fourth factory in Serbia
- Chinese move Gorenje production from Slovenia to Serbia
- Serbia ready to become full member of CERN
- Serbia plans to build 13 mln euro car battery factory in northern
- Serbia, US sign MoU in field of infrastructure
- PPF Group outlines Telenor Serbia plans